Neotropix, Inc. (Neotropix)

Oncology Corporate Profile

HQ Location

351 Phoenixville Pike
Malvern, PA 19355

Company Description

Neotropix Inc. develops and commercializes systemically deliverable oncolytic viruses for the treatment of solid tumors. By applying its proprietary screening process, called ViruScreen, to previously untapped viral resources, Neotropix has uncovered at least 19 entirely novel oncolytic candidates.


This company does not have any commercial products
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
NTX-010oncolytic virusSmall Cell Lung Cancer (SCLC)I

View additional information on product candidates here »


Recent News Headlines

There are no news items to display